2,6-Dichloro-3-fluoropyridine | CAS:52208-50-1

We serve 2,6-Dichloro-3-fluoropyridine CAS:52208-50-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
2,6-Dichloro-3-fluoropyridine

Chemical Name:2,6-Dichloro-3-fluoropyridine
CAS.NO:52208-50-1
Synonyms:2,6-Dichloro-3-fluoropyridine
 
Physical and Chemical Properties:
Density 1.5±0.1 g/cm3
Boiling Point 196.0±35.0 °C at 760 mmHg
Melting Point 44-46ºC
Molecular Formula C5H2Cl2FN
Molecular Weight 165.980
Flash Point 72.4±25.9 °C
Vapour Pressure 0.6±0.4 mmHg at 25°C
Index of Refraction 1.528
 
Specification:
Appearance:Off-white crystalline powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Organic synthesis.



Contact us for information like 2,6-Dichloro-3-fluoropyridine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2,6-Dichloro-3-fluoropyridine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2,6-Dichloro-3-fluoropyridine Use and application,2,6-Dichloro-3-fluoropyridine technical grade,usp/ep/jp grade.


Related News: Once they have decided how to make the compound, our staff in the production department manufacture a high quantity of APIs using the large reactors in our plant.dimethyl 2-(4-methoxycarbonyl-2-nitrophenyl)propanedioate manufacturer In addition, due to the complex process of changing the API supplier and the risk of uncertainty, the viscosity of pharmaceutical and specialty API companies is usually better.Bis(4-biphenylyl)amine supplier The clinical trial International Study of Phase 3 IV RigosErtib, or INSPIRE, was finalized following guidance received from the U.S. Food and Drug Administration and European Medicines Agency.2-Fluoro-5-(trifluoromethyl)pyridine vendor The clinical trial International Study of Phase 3 IV RigosErtib, or INSPIRE, was finalized following guidance received from the U.S. Food and Drug Administration and European Medicines Agency.On the other hand, the company has many new products in recent years, including Duqiao Base, Yancheng United Chemical and Dezhou United Chemical. These new products are mostly customized products with strong profitability, which has improved the gross profit margin of the industrial business.